SCHEMBL17127029

SCHEMBL17127029

CCOCCSC(C(=O)c1ccc2oc3ccccc3c(=O)c2c1)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ TTR P02766 5/20 0.47
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ ACSL1 P33121 4/20 0.40
▸ ACSL6 Q9UKU0 3/20 0.40
▸ MAOA P21397 2/20 0.40
▸ ACSL3 O95573 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ PTGER1 P34995 1/20 0.39
▸ PTGER3 P43115 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127030 0.93 MCHR1 (0.39) NPC1RAB9ATTRKDM4EALDH1A1
SCHEMBL17127337 0.79 KMT2A (0.35) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL17126979 0.77 PRSS1 (0.40) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL10944403 0.76 NPC1 (0.63) NPC1RAB9ATTRCASP3SENP8
SCHEMBL17127342 0.74 MEN1 (0.32) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL17126982 0.74 ACSL1 (0.39) NPC1RAB9AACSL1MAOAMEN1
SCHEMBL10942424 0.74 NPC1 (0.59) NPC1RAB9ATTRCASP3SENP8
SCHEMBL17126976 0.73 PPARA (0.40) NPC1RAB9ACYP2C9ALDH1A1HPGD
SCHEMBL17127022 0.71 PTGS2 (0.38) NPC1RAB9AMEN1KMT2ACYP2C9
SCHEMBL10943729 0.71 NPC1 (0.69) NPC1RAB9ATTRCASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS NPC1 4486/4885RAB9A 358/4885TTR 2210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback